US 12234516
Biomarkers of response to HIF-2-alpha inhibition in cancer and methods for the use thereof
granted A61PA61P35/00
Quick answer
US patent 12234516 (Biomarkers of response to HIF-2-alpha inhibition in cancer and methods for the use thereof) held by The Board of Regents of the University of Texas System expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P35/00